Entasis Therapeutics Holdings Inc (ETTX) Stock Analyst Earnings Estimates
NASDAQ:ETTX - Nasdaq - US2936141033 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 5M | 7M 40.00% | 335.141K -100.00% | 7.994M | 32.963M 312.36% | 80.791M 145.10% | 201.978M 150.00% | ||||
| EBITDA YoY % growth | -31.15M -64.64% | -38.05M -22.15% | -46.8M -23.00% | -55.139M -15.58% | -44.438M 3.46% | -36.529M 30.05% | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -31.34M -64.08% | -38.21M -21.92% | -46.94M -22.85% | -55.881M -15.53% | -54.042M 3.52% | -64.344M -22.98% | -62.269M 3.23% | -36.11M 42.01% | -43.409M -20.21% | -53.227M -22.62% | |
| Operating Margin | N/A | -764.20% | -670.57% | -16,673.94% | N/A | N/A | -778.97% | -109.55% | -53.73% | -26.35% | |
| EPS YoY % growth | N/A | N/A | -3.34 23.43% | -2.44 27.25% | -1.13 55.14% | -1.22 -11.98% | -1.17 3.90% | -0.64 45.65% | -0.78 -22.33% | -0.97 -24.78% |
| Q2 / 22 | Q3 / 22 | Q4 / 22 | |
|---|---|---|---|
| EPS Q2Q % growth | -0.30 -3.17% | -0.31 -17.69% | -0.29 -15.60% |
| Revenue Q2Q % growth | |||
| EBITDA Q2Q % growth | N/A | N/A | N/A |
| EBIT Q2Q % growth | -14.801M -11.28% | -16.442M -20.90% | -16.83M -32.11% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2022 Q2Q % growth | -0.32 -10.34% | -0.27 | -0.05 | -20.66% |
| Q4 2021 Q2Q % growth | -0.25 -92.31% | -0.27 | 0.02 | 8.37% |
| Q3 2021 Q2Q % growth | -0.26 29.73% | -0.28 | 0.02 | 7.31% |
| Q2 2021 Q2Q % growth | -0.29 62.82% | -0.33 | 0.04 | 11.84% |
| Q1 2021 Q2Q % growth | -0.29 74.78% | -0.37 | 0.08 | 21.39% |
| Q4 2020 Q2Q % growth | -0.13 87.74% | -0.40 | 0.27 | 67.31% |
| Q3 2020 Q2Q % growth | -0.37 -37.04% | -0.51 | 0.14 | 27.93% |
| Q2 2020 Q2Q % growth | -0.78 23.53% | -0.76 | -0.02 | -2.76% |
| Q1 2020 Q2Q % growth | -1.15 -16.16% | -1.02 | -0.13 | -12.49% |
| Q4 2019 Q2Q % growth | -1.06 | -0.69 | -0.37 | -53.39% |
| Q3 2019 Q2Q % growth | -0.27 | -0.88 | 0.61 | 69.44% |
| Q2 2019 Q2Q % growth | -1.02 | -0.61 | -0.41 | -67.32% |
| Q1 2019 Q2Q % growth | -0.99 | -0.77 | -0.22 | -28.60% |
Reported revenue can not be compared with estimates as they are in different currencies. Reported data is in USD, while estimates are .
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2020 Q2Q % growth | 335.141K | -335.141K | -100.00% | |
| Q3 2020 Q2Q % growth | -100.00% | 212.497K | -212.497K | -100.00% |
| Q2 2020 Q2Q % growth | 255K | -255K | -100.00% | |
| Q1 2020 Q2Q % growth | 318.75K | -318.75K | -100.00% | |
| Q4 2019 Q2Q % growth | 5.668M | -5.668M | -100.00% | |
| Q3 2019 Q2Q % growth | 7M | 4.037M | 2.963M | 73.37% |
| Q2 2019 Q2Q % growth | 3.876M | -3.876M | -100.00% | |
| Q1 2019 Q2Q % growth | 1.487M | -1.487M | -100.00% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A |
| Revenue | N/A | N/A | N/A | N/A |